Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOW FLOATERS? new board post 'em here.
http://www.investorshub.com/boards/board.asp?board_id=9090
The Goal: Finding the best, safest, most undervalued Fortune 1000, Mid Cap, and "non-micropenny" Stocks that can do a relatively certain two bagger, multibagger, or better within 6 months ~ 1 year... while significantly reducing the risk.
Strategy:
1. Significantly Undervalued
2. Projected Forecast (avg)
3. Projected EPS growth (avg)
4. Momentum
5. Earnings
6. Current or Emerging Leader In The Industry
7. Analysts with good track record
If you could afford to wait a few months, the companies listed below can potentially bring you just as good fortune as some of the penny stocks you've had before... all without the high-degree of risk involved in playing the pennies. NOTE: sometimes you may see penny picks here, but rest assured they must be listed, reporting, and meet the criteria to make it here.
RULES: Stay on topic/abide by the TOS. Don't come here to complain about my picks or to whine about your ex unless it's funny.If you have good DD, especially if it's a negative one, please do share it here but don't spam it to death.
DISCLAIMER: I'M NOT RESPONSIBLE FOR ANY LOSSES OR DAMAGES RESULTING FROM THE INFORMATION ON THIS BOARD. READ THIS BOARD AT YOUR OWN RISK. THIS LIST IS REALLY JUST A REFLECTION OF WHAT I'M BUYING/SELLING PERSONALLY.
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
Scans for 2007
SPN $30.56 Superior Energy
GDI $36.56 Gardner Denver
ASFI $33.85 Asta Funding
Greatest Multibagger Potentials
(Deeply Undervalued + Earnings Forecast + Momo)
XRM $10.26 XERIUM TECHNOLOGIES
ICGE $10.80 INTERNET CAPITAL
GETI $33.04 GENTEK INC
KKD $10.38 KRISPY KREME DOUGHNUTS
LTXX $5.13 LTX CORPORATION
PDS $23.01 PRECISION DRILLING
ASPV $17.48 ASPREVA PHARMACEUTICALS
------------------------------------------------------------
------------------------------------------------------------
Performance from Fog's Jan 2005 Portfolio:
VLO: $23 as of Jan 2005 -> sold $59.84 4/4/2006 (Almost 3 bagger)
GGB: $11 as of Jan 2005 -> sold $25 as of Mar 2006 (2+ Bagger!)
RIO: $25 as of Jan 2005 -> sold $48.95 as of 4/4/2006 (NICE!)
AMPX: $11 as of Dec 2004 -> sold $19.75 as of 4/4/2006 (Near 2 Bagger!)
AGII: $23 as of Jan 2005 -> sold $35 as of 4/4/2006
SNSA: $28 as of Jan 2005 -> sold $33 as of Mar 2006
TCX: $0.68 as of Jan 2005 -> sold $0.95
UTX: $50 as of Jan 2005 -> $66
ITWO: Purchased at $16.46, $20 as of 11/2006 (will sell when it reaches $70)
CELL: $31.26 noticed as of 4/7/06, $12.15 as of 11/2006 (possible split?)
NETC: $5.24 noticed as of 4/7/06, $10.23 as of 11/2006 (TWO BATTER)
Watched
IHC: $23.25 4/4/2006 -> $21.50 as of 11/2006
GETI: $18.49 as of Mar 13, 2006 -> $33.03 as of 11/2006 (Two Bagger!)
ARLP: $35.33 4/4/2006 -> $35.07 as of 11/2006
DISCLAIMER: BUY AT YOUR OWN RISK. I'M NOT RESPONSIBLE FOR ANY LOSSES OR DAMAGES RESULTING FROM THE INFORMATION ON THIS BOARD. READ AT YOUR OWN RISK. THIS LIST IS REALLY JUST A REFLECTION OF WHAT I'M BUYING/SELLING PERSONALLY.
(Nasdaq:ITWO $19.30), i2 to Present at the Fourth Annual North American Supply Chain & Logistics Summit
Fourth Annual North American Supply Chain & Logistics Summit
DALLAS--(BUSINESS WIRE)--i2 Technologies, Inc. will present at the Fourth Annual North American Supply Chain & Logistics Summit in Austin, Texas, Dec. 4-5, 2006.
Mohan Balachandran, vice president of sales and marketing with i2’s Consumer Industries Group, will speak on the topic of “The Demand Driven Supply Chain: Achieving Greater Customer Satisfaction, Greater Profitability, and Abolishing Inventory” on Tuesday, Dec. 5 at 2:10 p.m. CST. The presentation will highlight how several industry leading companies have teamed up with i2 to enable demand-driven supply networks and, as a result, have made substantial improvements in terms of forecast accuracy, retailer collaboration, inventory level optimization, asset utilization and transport cost savings.
i2’s new-generation solutions for consumer industries are designed to help companies optimize across the multiple corporate entities in an extended supply chain in order to reduce costs, increase margin, and improve end-customer delivery performance. Balachandran is responsible for the overall strategy and market direction of the company’s consumer industries practice. He has profound knowledge and understanding of the supply chain needs of various consumer-focused and brand-oriented companies. Brand strategy, demand management, and sales and operations management are his key areas of expertise.
Those interested in meeting with i2 at the event can contact Mark Mirsky at mark_mirsky@i2.com. More information about the event is available at http://www.scmna.worldtradeco.com/index.asp.
About i2
i2 helps business leaders make better supply chain decisions. i2's flexible new-generation solutions are designed to synchronize demand and supply across ever-changing global business networks. i2's innovative supply chain management tools and services are pervasive in a wide cross-section of industries; 20 of the AMR Research Top 25 Global Supply Chains belong to i2 customers. Learn more at www.i2.com.
i2 is a registered trademark of i2 Technologies US, Inc. and i2 Technologies, Inc.
PYPR surprised by the volume, but the retrace was expected. Still holding and my top pick. I wish folks would quit with all the belly aching and just let the momo flow!
PLYCF looking better today. Just like PYPR is doing now, PLYCF underwent consolidation and moving back up now. Back in.
TVCE under accumulation. Will enter this week.
I cancelled my microcap subscription. What a piece of junk, always down.
PYPR the best subpenny play out there. Still under the radar. When the herd comes, she goes parabolic.
Deeply undervalued NYSE/NASDAQ stocks with good fundamentals.
4 bagger potentials within a year or two. Do your own DD!
XRM
ICGE
GETI
KKD
LTXX
PDS
ASPV
!!!!!! NEW STOCKS UPDATE !!!!!!!!!
Do your own DD! And contribute! Two heads are better than one!
Most probable gainers
SPN $30.56 Superior Energy
GDI $36.56 Gardner Denver
ASFI $33.85 Asta Funding
Greatest Multibagger Potentials
XRM $10.26 XERIUM TECHNOLOGIES
ICGE $10.80 INTERNET CAPITAL
GETI $33.04 GENTEK INC
KKD $10.38 KRISPY KREME DOUGHNUTS
LTXX $5.13 LTX CORPORATION
PDS $23.01 PRECISION DRILLING
ASPV $17.48 ASPREVA PHARMACEUTICALS
Went all in on PYPR this morning. Still think she's a 10-bagga!!!!!!!!!!!!!!!!
!!!!!!! NEW SCANS !!!!!!!!
New scans to hold long term (about 1 year or more). All of them are very good in my opinion but need your help doing DD on these companies over the next few days. It will help narrow these down to add to the final list.
MRO 89.85 MARATHON OIL CORP
VNT 19.65 CIA ANONIMA NACIONAL
FTO 30.48 FRONTIER OIL CORP
ASPV 17.48 ASPREVA PHARMACEUTICALS
CP 55.15 CANADIAN PACIFIC
LGND 11.74 LIGAND PHARMACEUTICALS
PBR 91.49 PETROLEO BRASILEIRO
AMKR 9.34 AMKOR TECHNOLOGY
TSO 67.29 TESORO CORP
ALJ 29.09 ALON USA ENERGY INC
CEO 86.76 CNOOC LTD
PGS 62.73 PETROLEUM GEO-SERVICES
NHY 24.70 NORSK HYDRO ASA
VLO 54.25 VALERO ENERGY CORPORATION
WMCO 13.86 WILLIAMS CONTROLS
XRM 10.26 XERIUM TECHNOLOGIES
ELRN 12.14 ELRON ELECTRONIC
PTR 116.38 PETROCHINA CO LTD
ICGE 10.80 INTERNET CAPITAL
LTXX 5.13 LTX CORPORATION
GETI 33.04 GENTEK INC
ITWO big fat detailed chart
PYPR indicator analysis
RSI Neutral
MACD Bullish
Average Volume 89 million
William is Bullish
Stochastics neutral
Volume-Price Trend Bullish
10 Day Trend Bullish
40 Day Trend Bullish
100 Day Trend Bullish
Put These on Radar === CBP.V, LMA.T, VMCS.OB, CTG.V
CBP.V === Uranium is super hot
http://www.stockscores.com/quickreport.asp?ticker=v.cbp
LMA.T === $40 million in the till and a thumbs up from Peter Grandich
http://www.stockscores.com/quickreport.asp?ticker=t.lma
VCMCS.OB === PR Campaign Will Kick Off Next Week
http://www.stockscores.com/quickreport.asp?ticker=vmcs&x=10&y=10
CTG.V === Time to pick up cheap stock
http://www.stockscores.com/quickreport.asp?ticker=v.CTG
OT: Just for Fun!!!
A boy goes to the drug store with his dad and sees the condom display.
Boy: "Dad, why do they do packs of one condom?"
Dad: "Those are for the high-schoolers for Friday nights."
Boy: "So, why do they make packs of three?"
Dad: "For the college guys for Friday, Saturday and Sunday nights."
Boy: "Then why do they make packs of 12?"
Dad: "Those are for married couples -- you know, January, February, March."
LOLLLLL I loud and clear chief!
Been adding whenever I can.
POUNDING DA TABLE HERE FOG!!!!!!!!!!!!!!!! PYPR A 10 BAGGER FROM HERE !!!!!!!!!!!!!!!!!! YOU HEAR ME!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Captain, Fog. Going all in on PYPR tomorrow morning. Just freed up some cash. PYPR is a sure 10 bagger from here. You with me, Captain?
lol. Hey buddy. Don't say I didn't give you the heads up on this one early!
DOH!!!!!!! So it's a buy 1 get two free deal now?
I'm transferring some funds to add.
Thanks for the great info, bro.
HWYI's subsidiary DDI looks just as good if not better then OptiCon two great companies two great spin-offs.
Huge Huge Huge News on HWYI. This sets up two spin-offs now. The news is on the RIMM news wire too. This is quite a difference in credibility over IDWD, huh?
ETIM killed itself with the relentless dilution. They need to let her breathe a little bit, dilute a little, breathe a little, and so on.
TVCE lookin very nice and showing strength.
According to Robert Corr, president of RushNet, Inc, the Company plans to declare a special dividend of one unit of Apple Rush Company, Inc. per a fixed number of RushNet, Inc. shares. The unit will consist of one free-trading share of Apple Rush Company, Inc., an OTC bulletin board company, and two attached warrants.
The first warrant will give the unit holder the right to buy one free-trading share of Apple Rush Company, Inc. at 66 2/3% of the closing price averaged over the first five days of public trading of said company. This warrant will expire in 45 days from commencement of trading in the underlying security.
The second warrant will also give the unit holder the right to buy one free-trading share of Apple Rush Company, Inc. The second warrant will be exercisable until 29 June 2007 at a price equal to twice the closing price averaged over the first five days of public trading of Apple Rush Company, Inc.
Corr said complete specifics of the dividend transaction would be forthcoming.
While RushNet, Inc. expects to complete, before 90 days elapses, the spin-off of its subsidiary Apple Rush Company, Inc. to the OTC bulletin board, the timetables of all transactions of this type are ultimately governed by rules and regulations of the U.S. Securities and Exchange Commission.
big news for RSHN... retired 2 billion shares ,New spin off company apple rush company that we gime in a diviy , look'n to buy in gardens distubion, new products comeing from garden deal and apple rush company deal rush.......japan wants e-water ... I think Corr is look for a buyout on this apple rush company spinoff......and NOBO list come'n out anyday now ,corr is try to get the shorts.....apple rush company will not be in the pinks.....
TVCE accumulate now, for a run in the near future. Won't run today, but it will within a few weeks. Accumulate.
I bought RSHN at .0012 and sold the same day at .0012. Then it made its parabolic move to .01. Thankfully, I bought back in at .003 and rode it to about .008, then sold all out to buy into the dilution machine, GZFX. Live and learn. LOL
PYPR holding gains from last week extremely well.
I had RSHN at .0005 or so last year and sold everything when it went up some. Immediately after I hit the sell button, it went straight through the roof. LOLL
yeah, i used to have a position in RHSN. so, good news is coming?
hey fog do you like RSHN big news come'n read PR"S
Simple, the list is only for large cap / midsize cap stocks that are trading on NYSE/NASDAQ/Amex... NNVC is still a pinky
I do own a ton of nnvc and it's one of my most favorite stock of all stocks.
lol... that's almost as short as a dissertation
Why VisualMED?
VisualMed (VMCS.OB)
VisualMED is the only existing, comprehensive clinical informatics system that saves time and money while encouraging practitioners to practice the highest quality medicine. Rather than re-duplicating paper systems, it replaces them without generating wasteful make-work.
VisualMED - clinically-based, reality-checked
In addition to ease of use for healthcare providers, VisualMED's compelling advantages are that it saves time and money and is fully scaleable to suit any clinical environment.
VisualMED can be fully functional on either a single ward or across the wards of a large hospital, and can be introduced module by module as time and budget permit
VisualMED incorporates all clinical medical and nursing functions with results reporting and image retrieval and interfaces with existing legacy systems.
VisualMED modules can pay for themselves over 24 to 36 months depending on the size of the installation and local practice habits, without imposing "prescribing rules" for practitioners.
Frequently asked questions:
How can VisualMED clinical system screens function in clinical environments unique to each hospital site?
VisualMED screens are constructed using parametric components. Though within the system order entry screens there are a number of different ways different users may arrive at the same set of completed prescriptions, those same screens can often be configured to function along broadly different, though “parallel” lines of function. The most striking example of this parallelism is in the existence of two broad methods of drug order entry. In one method of screen flow, the user chooses the drug and drug “format” from a single list. In the alternative method, the user selects from a shorter list of drugs and chooses the drug format in a second step. The latter method, though seemingly adding an “unnecessary” second step to the order entry process, was built as a parametric addition to the system as it is most appropriate to the practice of pediatric medicine. It was developed specifically at the request of our first pediatric installation.
At a more granular level (ie., for any given configuration), VisualMED screens are already “adapted” to the requirements of most sites that already have developed tried-and-true approaches to order entry and clinical charting. This is because most VisualMED screens allow the user to prescribe and chart according to more than a single “allowed-method.” There is usually more than one route to accomplish a given order entry or charting task, and therefore it is highly likely that at least one existing VisualMED method “already” corresponds to the order of work chosen by any individual user. Without making any modifications to the system screens as they currently exist, a diversity of approach is already present: In order entry, orders can be generated en-bloc or one at a time; administration times can be specified broadly or exactly; navigation can be alphabetical or “logical,” orders can be prescribed individually or may belong to ordersets. In the nursing activities screen, nurses can review scheduled activities using an icon display or a tabular display; they can review the schedule for the entire care unit, for selected rooms belonging to the units, or for selected nurses working on the unit. The nurse can chart his or her data entries through the activities screen or directly in the MAR, depending on which screen they feel more naturally reflects their existing approach to the clinical process. In results reporting, graphs can be navigated in “analog” mode or in “value” mode.
VisualMED manages clinical processes as “modular,” ie., as related to the individual specialties of medicine and surgery. Orders and procedures relevant to only certain specialties or sites may be displayed only at those sites, wards or services so that workflow documentation and order entry follows established local requirements.
VisualMED is actually capable of maintaining individual, but linked, clinical information systems at each of the principal hospital sites belonging to a Hospital System. Therefore, the navigation flow, the order types available, the drug listing and test listing content, as well as all of the decision support related to each of these, may be tailored to the individual sites. Additional screen development may be necessary to deal with clinical investigation or other projects that would be unique to each site belonging to a university system.
How is the VisualMED “clinician’s desktop” designed?
The VisualMED desktop itself, like all other VisualMED screens, may be navigated using the keyboard or touch. Mouse may also be used. « Hotkey » navigation allows the user to rapidly access clinical functions documented by doctors and nurses, all of which are displayed in plain sight at all times. The screens are open and uncluttered and color navigational cues are used consistently across all screens. Drop-down menus requiring users to « guess » at what lies beneath are avoided. Doctors and nurses navigate an electronic interface which, rather than borrowing from traditional paper charting methods, actually reflects clinical workflow as performed by the clinical staff. Our unique U.I. is based on our successful « legacy » U.I., originally developed on the clinical teaching units of the Department of Medicine at the Royal Victoria Hospital, specifically for the practice of tertiary care medicine and surgery. In our second generation system, we have taken those features proven successful over the past seven years and incorporated them into a state-of-the-art Windows interface.
The desktop may be configured by the client so that patient names are entirely hidden until logon, while nevertheless showing the presence of screen icons indicating the existence of certain critical clinical situations. It may also be configured to contain button controls giving access to non-system screens and/or internet data sources. Automatic signoffs prevent unauthorized access and no patient data may be viewed without biometric logon. Logon is, in fact, entirely biometric and no PIN or password is required. This streamlined process results in a false (+) rate of less than one in 2,500,000.
The principal physicians’ screen, in fact a « desktop », displays the list of hospitalized patients on the specific unit. The list can be explored by using the up and down arrow keys or the TAB key, or touch to move from column to column. At the top of the screen are located buttons that give access to other system clinical functions, including the VisualMED electronic patient record. To the left of each patient’s name may be displayed one or more icons containing critical information relating to the appropriate patient.
icons indicate that the specified patient has a positive microbiological culture for a body fluid AND is not receiving appropriate antibiotic therapy; has at least one numerical laboratory test result outside of a defined normal (or “alerts”) range; has at least one vital sign reading outside of a defined normal (or “alerts”) range; that there is a message concerning the patient to the attention of the patient’s doctor; that the patient is in a state of dehydration or hypervolemia. The biohazard icon may also be displayed in such a way as to indicate that though a culture is positive, the patient is already receiving appropriate antibiotic coverage. As well, the laboratory alerts icon may be display so as to indicate that laboratory results have arrived on the ward within the past hour for designated patients. The message icon stores not only text messaging from other system users concerning the designated patient, but may store voice messages as well. To access any additional icon “content,” the user highlights the icon of interest, and simply presses ENTER and VisualMED will open a small window containing additional related information.
VisualMED displays a number of icon images in the principal nursing screen that specify information unique to specific patients. Notification of the existence of pre-op or post-op orders written by a physician is given by displaying icon content to that effect. Pre-op and post-op orders may be accessed directly through the appropriate icon.
VisualMED displays an icon to the left of the names of patients scheduled for blood tests. Upon opening the icon, the nurse or technician may then sign-off the blood drawing activity, with the date and time sent immediately via HL7 to the appropriate laboratory. A hemodialysis icon is displayed to the left of the names of the patients who are dialyzed and have drug orders associated with the dialysis schedule. The message and discharge icons available in the physicians’ desktop are also available in the nursing desktop.
Desktops unique to the functions of the pharmacy and of the unit coordinator also exist within two additional principal VisualMED screens. Paramedical users access the system using one of the four currently existing principal screens.
Which VisualMED modules and functions take advantage of portable wireless devices?
All VisualMED modules and functions currently run in a wireless environment using a computing tablet. The tablet displays the full VisualMED desktop at 1024x768 resolution, and allows for the performance of all system functions. All entries are communicated in real-time to the system tables, bidirectionally.
By-the-bedside clinical signs data entry and voice messaging is currently available using a hand-held device which allows for touch data entry. Voice messaging regarding the currently specified patient is communicated to system tables as a WAV file where it is “stored” inside the same message icon displayed on the principal system screens used to display text messages. Message icons displayed on workstations designated as “non-public,” ie., that are not located in a designated public space, such as a corridor, will play-back stored voice messages when opened by users who have access rights to this function.
Can VisualMED results reporting capture data for both clinical and research purposes?
Whether or not a particular laboratory examination was initially prescribed through VisualMED, all numerical, text, and image data stored originating on the appropriate laboratory system is available for review through the VisualMED clinical information system. Clinical data which was prescribed as part of a researcher’s protocol, because it nevertheless originates in one of the hospital laboratory systems is automatically forwarded to VisualMED tables. Data required purely for research or protocol purposes may be defined for efficient capture through the use of the VisualMED Protocol Data Administration screens. Initially developed for the VisualMED VisualONCOLOGY module, the flexible design of that screenset allows its use to be generalized to apply to any defined research protocol, including those outside of the domain of oncology. Because the VisualMED CIS (clinical information system) allows for the ad hoc definition of clinical modules, a module may be defined to which only specified user groups have access, and such groups may be defined to contain just a single individual. With no special modification to the VisualMED clinical information system, clinical protocols may be maintained for which only a few individuals have access, including the access to the sets of data defined as associated for that module through the Protocol Data Administration screens referred to above. Though VisualMED currently supports the concept of “sensitive” data, limiting the disclosure of such data to the prescriber and the patient’s attending physician, with respect to the maintenance of “private” data, field changes to the current table structure would be required, but are customizable at the request of the client.
How can the VisualMED clinical information system support disease management programs?
A disease management program can be defined as a grouping of multidisciplinary services targeted at patients with a specific family of diseases. The VisualMED CIS currently supports disease management programs through its incorporation of specialty-related ordersets and protocols that may be easily modified, without coding, so that they apply to the reality of the patient population treated at individual sites of a healthcare organization. Though ordersets and protocols may be designed to reflect practice at individual sites, because the system makes use of its own internal data dictionary, data collected at each site may be meaningfully compared with respect to outcomes analysis. Each protocol can also be identified with predetermined outcome targets. All CIS clinical data, including data captured in the patient chart and physician’s note, is coded and therefore also available for outcomes analysis. The VisualMED CIS promotes the implementation of disease management programs through the seamless integration of the documentation of all clinical activities by all members of the health care team, including physicians, nurses, consultants, residents, and paramedical personnel. The CIS already contains a basic set of clinical reports that may be used as case-finding tools, identifying patients at risk for clinical deterioration or poor outcome. The longitudinal CIS patient record promotes continuity of care, and, in conjunction with VisualMED Consent Management included with the CIS Ambulatory Care functionality, gives staff in off-site locations access to a unified electronic patient record.
CIS features that facilitate the implementation of a disease management program include the following:
· Specialty-driven ordersets and protocols that reflect best practice at individual hospital sites with varied patient populations, integrated with MAR and Care Plan.
· Target outcomes that may be attached to defined protocols.
· Built-in case finding tools
· Integration of the clinical process and of the documentation of the clinical process, for all members of the healthcare team.
· Entirely coded clinical data entry by health care personnel.
· Longitudinal electronic medical record
· Consent Management allowing on and off-site access to all or part of a patient’s electronic record.
· Audit capability for evaluation of clinical outcomes.
For more information on the VisualMED System, click here.
I'm actually going to lowes right now. Lets see if they are there too. Got 2 wallets ready. LOL
Got any other funny jokes? BTW, which stocks are u playing
Hell yeah! That was a classic!
ROFLLLLLLLL u still remember that joke. haha
Yes sir.. Have you been robbed at Home depot lately? LOL!!
i believe ya. just look at them BB... very tight
Have you checked out RENG... bullish as heyelllll
pypr just a matter of time before she goes parabolic too!!!
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
388
|
Created
|
03/13/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |